Nutrient supplementation: Improving male fertility fourfold

Seminars in Reproductive Medicine

Volumn 31, Issue 4, 2013, Pages 293-300

  Mora Esteves, Cesar ^a   Shin, David ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

antioxidant therapy; male infertility; oxidative stress; vitamin supplements

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; ASTAXANTHIN; CARNITINE; COPPER; FOLIC ACID; GLUTATHIONE; LYCOPENE; MENEVIT; PENTOXIFYLLINE; PLACEBO; RETINOL; SELENIUM; UBIDECARENONE; UNCLASSIFIED DRUG; ZINC; ZINC SULFATE; TRACE ELEMENT;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIRTH RATE; DNA DAMAGE; DNA SYNTHESIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EMBRYO GROWTH; ENERGY METABOLISM; FATTY ACID OXIDATION; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; LIPID PEROXIDATION; LIVE BIRTH; LOW DRUG DOSE; MALE FERTILITY; MALE INFERTILITY; META ANALYSIS; OXIDATIVE STRESS; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RNA SYNTHESIS; SEMINAL PLASMA; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ANIMAL; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; NUTRITIONAL DEFICIENCY; PATHOPHYSIOLOGY; PREGNANCY; SEVERITY OF ILLNESS INDEX;

ANIMALS; ANTIOXIDANTS; DEFICIENCY DISEASES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; MICRONUTRIENTS; OXIDATIVE STRESS; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED; SEVERITY OF ILLNESS INDEX;

EID: 84879220762     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1345277     Document Type: Article

References (114)

1. Sharlip I. D., Jarow J. P., Belker A. M., et al. Best practice policies for male infertility. Fertil Steril: 2002; 77 5 873 882
2. World Health Organization WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. Cambridge Cambridge University Press: 1999; 1 86
3. Warren J. S., Johnson K. J., Ward P. A. Oxygen radicals in cell injury and cell death. Pathol Immunopathol Res: 1987; 6 5-6 301 315
4. Kefer J. C., Agarwal A., Sabanegh E. Role of antioxidants in the treatment of male infertility. Int J Urol: 2009; 16 499 57
5. Saleh R. A., Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. J Androl: 2002; 23 6 737 752
6. Aitken R. J. Free radicals, lipid peroxidation and sperm function. Reprod Fertil Dev: 1995; 7 4 659 668
7. Baker H. W., Brindle J., Irvine D. S., Aitken R. J. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril: 1996; 65 2 411 419
8. Mahfouz R., Sharma R., Sharma D., Sabanegh E., Agarwal A. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertil Steril: 2009; 91 3 805 811
9. Sharma R. K., Agarwal A. Role of reactive oxygen species in male infertility. Urology: 1996; 48 6 835 850
10. Kemal Duru N., Morshedi M., Oehninger S. Effects of hydrogen peroxide on DNA and plasma membrane integrity of human spermatozoa. Fertil Steril: 2000; 74 6 1200 1207
11. Misro M. M., Choudhury L., Upreti K., et al. Use of hydrogen peroxide to assess the sperm susceptibility to oxidative stress in subjects presenting a normal semen profile. Int J Androl: 2004; 27 2 82 87
12. Sikka S. C. Relative impact of oxidative stress on male reproductive function. Curr Med Chem: 2001; 8 7 851 862
13. Agarwal A., Saleh R. A., Bedaiwy M. A. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril: 2003; 79 4 829 843
14. Sikka S. C. Role of oxidative stress and antioxidants in andrology and assisted reproductive technology. J Androl: 2004; 25 1 5 18
15. Wang X., Sharma R. K., Sikka S. C., Thomas A. J. Jr, Falcone T., Agarwal A. Oxidative stress is associated with increased apoptosis leading to spermatozoa DNA damage in patients with male factor infertility. Fertil Steril: 2003; 80 3 531 535
16. Bonanomi M., Lucente G., Silvestrini B. Male fertility: core chemical structure in pharmacological research. Contraception: 2002; 65 4 317 320
17. Tremellen K. Oxidative stress and male infertility-a clinical perspective. Hum Reprod Update: 2008; 14 3 243 258
18. Bykova M., Athayde K., Sharma R., Jha R., Sabanegh E., Agarwal A. Defining the reference value of seminal reactive oxygen species in a population of infertile men and normal healthy volunteers. Fertil Steril: 2007; 88 305
19. Showell M. G., Brown J., Yazdani A., Stankiewics M. T., Hart R. J. Antioxidants for male subfertility. Cochrane Database Syst Rev: 2011; 1 CD007411
20. Aitken R. J., Koopman P., Lewis S. E. Seeds of concern. Nature: 2004; 432 7013 48 52
21. Tarozzi N., Bizzaro D., Flamigni C., Borini A. Clinical relevance of sperm DNA damage in assisted reproduction. Reprod Biomed Online: 2007; 14 6 746 757
22. Deepinder F., Cocuzza M., Agarwal A. Should seminal oxidative stress measurement be offered routinely to men presenting for infertility evaluation? Endocr Pract: 2008; 14 4 484 491
23. Jeulin C., Lewin L. M. Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update: 1996; 2 2 87 102
24. Frenkel R. A., Mc Garry J. D., eds. Carnitine Biosynthesis, Metabolism and Function. [Italian edition]. New York Academic Press: 1984; 271 284
25. Peluso G., Nicolai R., Reda E., Benatti P., Barbarisi A., Calvani M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol: 2000; 182 3 339 350
26. Vicari E., Calogero A. E. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod: 2001; 16 11 2338 2342
27. Lenzi A., Lombardo F., Sgrò P., et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril: 2003; 79 2 292 300
28. Gattuccio F., De Rose A. F., Latteri M. A., eds. Varicocele. Palermo, Italy Cofese Editore: 2000; 205 210
29. Lenzi A., Sgrò P., Salacone P., et al. A placebo-controlled double-blind randomized trial of the use of combined l -carnitine and l -acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril: 2004; 81 6 1578 1584
30. Cavallini G., Ferraretti A. P., Gianaroli L., Biagiotti G., Vitali G. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl: 2004; 25 5 761 770, discussion 771-772
31. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J: 1992; 123 6 1726 1727
32. Menchini-Fabris G. F., Canale D., Izzo P. L., Olivieri L., Bartelloni M. Free L-carnitine in human semen: its variability in different andrologic pathologies. Fertil Steril: 1984; 42 2 263 267
33. Bornman M. S., du Toit D., Otto B., Müller I. I., Hurter P., du Plessis D. J. Seminal carnitine, epididymal function and spermatozoal motility. S Afr Med J: 1989; 75 1 20 21
34. Johansen L., Bohmer T. Carnitine-binding related suppressed oxygen uptake by spermatozoa. Arch Androl: 1978; 1 4 321 324
35. Radigue C., Es-Slami S., Soufir J. C. Relationship of carnitine transport across the epididymis to blood carnitine and androgens in rats. Arch Androl: 1996; 37 1 27 31
36. Golan R., Weissenberg R., Lewin L. M. Carnitine and acetylcarnitine in motile and immotile human spermatozoa. Int J Androl: 1984; 7 484 494
37. Bartellini M., Canale D., Izzo P. L., Giorgi P. M., Meschini P., Mechini-Fabris G. F. L-carnitine and acetylcarnitine in human sperm with normal and reduced motility. Acta Eur Fertil: 1987; 18 1 29 31
38. Costa M., Canale D., Filicori M., D'lddio S., Lenzi A. Italian Study Group on Carnitine and Male Infertility L-carnitine in idiopathic asthenozoospermia: a multicenter study. Andrologia: 1994; 26 3 155 159
39. Vitali G., Parente R., Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res: 1995; 21 4 157 159
40. Moncada M. L., Vicari E., Cimino C., Calogero A. E., Mongioì A., D'Agata R. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil: 1992; 23 5 221 224
41. Ehrenkranz R. A. Vitamin E and the neonate. Am J Dis Child: 1980; 134 12 1157 1166
42. Palamanda J. R., Kehrer J. P. Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione. Lipids: 1993; 28 5 427 431
43. Porter R., Whelan J., eds. Biology of vitamin E. Ciba Foundation Symposium 101. Proceedings of a Symposium on Biology of Vitamin E. London Pitman Press: 1984; 1430 1439
44. Suleiman S. A., Ali M. E., Zaki Z. M., el-Malik E. M., Nasr M. A. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl: 1996; 17 5 530 537
45. Kessopoulou E., Powers H. J., Sharma K. K., et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril: 1995; 64 4 825 831
46. Dawson E. B., Harris W. A., Rankin W. E., Charpentier L. A., McGanity W. J. Effect of ascorbic acid on male fertility. Ann N Y Acad Sci: 1987; 498 312 323
47. Jacob R. A., Pianalto F. S., Agee R. E. Cellular ascorbate depletion in healthy men. J Nutr: 1992; 122 5 1111 1118
48. Fraga C. G., Motchnik P. A., Shigenaga M. K., Helbock H. J., Jacob R. A., Ames B. N. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A: 1991; 88 24 11003 11006
49. Lewis S. E., Sterling E. S., Young I. S., Thompson W. Comparison of individual antioxidants of sperm and seminal plasma in fertile and infertile men. Fertil Steril: 1997; 67 1 142 147
50. Thiele J. J., Friesleben H. J., Fuchs J., Ochsendorf F. R. Ascorbic acid and urate in human seminal plasma: determination and interrelationships with chemiluminescence in washed semen. Hum Reprod: 1995; 10 1 110 115
51. Baker H. W., Brindle J., Irvine D. S., Aitken R. J. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril: 1996; 65 2 411 419
52. Rolf C., Cooper T. G., Yeung C. H., Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod: 1999; 14 4 1028 1033
53. Giovenco P., Amodei M., Barbieri C., Fasani R., Carosi M., Dondero F. Effects of kallikrein on the male reproductive system and its use in the treatment of idiopathic oligozoospermia with impaired motility. Andrologia: 1987; 19 Spec No 238 241
54. Moilanen J., Hovatta O. Excretion of alpha-tocopherol into human seminal plasma after oral administration. Andrologia: 1995; 27 3 133 136
55. Ursini F., Heim S., Kiess M., et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science: 1999; 285 5432 1393 1396
56. Roveri A., Casasco A., Maiorino M., Dalan P., Calligaro A., Ursini F. Phospholipid hydroperoxide glutathione peroxidase of rat testis. Gonadotropin dependence and immunocytochemical identification. J Biol Chem: 1992; 267 9 6142 6146
57. Alvarez J. G., Storey B. T. Lipid peroxidation and the reactions of superoxide and hydrogen peroxide in mouse spermatozoa. Biol Reprod: 1984; 30 4 833 841
58. Surai P. F., Blesbois E., Grasseau I., et al. Fatty acid composition, glutathione peroxidase and superoxide dismutase activity and total antioxidant activity of avian semen. Comp Biochem Physiol B Biochem Mol Biol: 1998; 120 3 527 533
59. Wallace E., Cooper G. W., Calvin H. I. Effects of selenium deficiency on the shape and arrangement of rodent sperm mitochondria. Gamete Res: 1983; 4 389 399
60. Wallace E., Calvin H. I., Ploetz K., Cooper G. W. Functional and developmental studies on the role of selenium in spermatogenesis. In: Combs G. F. Jr, Spallholz J. E., Levander O. A., Oldfield J. E., eds. Selenium in Biology and Medicine, Part A. New York AVI Publishing Co.: 1987;:112, 181-196
61. Watanabe T., Endo A. Effects of selenium deficiency on sperm morphology and spermatocyte chromosomes in mice. Mutat Res: 1991; 262 2 93 99
62. Noack-Füller G., De Beer C., Seibert H. Cadmium, lead, selenium, and zinc in semen of occupationally unexposed men. Andrologia: 1993; 25 1 7 12
63. Bleau G., Lemarbre J., Faucher G., Roberts K. D., Chapdelaine A. Semen selenium and human fertility. Fertil Steril: 1984; 42 6 890 894
64. Behne D., Gessner H., Wolters G., Brotherton J. Selenium, rubidium and zinc in human semen and semen fractions. Int J Androl: 1988; 11 5 415 423
65. Saaranen M., Suistomaa U., Kantola M., Saarikoski S., Vanha-Perttula T. Lead, magnesium, selenium and zinc in human seminal fluid: comparison with semen parameters and fertility. Hum Reprod: 1987; 2 6 475 479
66. Roy A. C., Karunanithy R., Ratnam S. S. Lack of correlation of selenium level in human semen with sperm count/motility. Arch Androl: 1990; 25 1 59 62
67. Burton G. W., Traber M. G. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr: 1990; 10 357 382
68. Maiorino M., Coassin M., Roveri A., Ursini F. Microsomal lipid peroxidation: effect of vitamin E and its functional interaction with phospholipid hydroperoxide glutathione peroxidase. Lipids: 1989; 24 8 721 726
69. Vézina D., Mauffette F., Roberts K. D., Bleau G. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res: 1996; 53 1-3 65 83
70. Keskes-Ammar L., Feki-Chakroun N., Rebai T., et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl: 2003; 49 2 83 94
71. Comhaire F. H., El Garem Y., Mahmoud A., Eertmans F., Schoonjans F. Combined conventional/antioxidant "Astaxanthino" treatment for male infertility: a double blind, randomized trial. Asian J Androl: 2005; 7 3 257 262
72. Klebanov G. I., Kapitanov A. B., Teselkin YuO., et al. The antioxidant properties of lycopene. Membr Cell Biol: 1998; 12 2 287 300
73. Gupta N. P., Kumar R. Lycopene therapy in idiopathic male infertility-a preliminary report. Int Urol Nephrol: 2002; 34 3 369 372
74. Lenzi A., Culasso F., Gandini L., Lombardo F., Dondero F. Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod: 1993; 8 10 1657 1662
75. Hansen J. C., Deguchi Y. Selenium and fertility in animals and man-a review. Acta Vet Scand: 1996; 37 1 19 30
76. Ursini F., Heim S., Kiess M., et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science: 1999; 285 5432 1393 1396
77. Gressier B., Cabanis A., Lebegue S., et al. Decrease of hypochlorous acid and hydroxyl radical generated by stimulated human neutrophils: comparison in vitro of some thiol-containing drugs. Methods Find Exp Clin Pharmacol: 1994; 16 1 9 13
78. Erkkilä K., Hirvonen V., Wuokko E., Parvinen M., Dunkel L. N-acetyl-L-cysteine inhibits apoptosis in human male germ cells in vitro. J Clin Endocrinol Metab: 1998; 83 7 2523 2531
79. Oeda T., Henkel R., Ohmori H., Schill W. B. Scavenging effect of N-acetyl-L-cysteine against reactive oxygen species in human semen: a possible therapeutic modality for male factor infertility? Andrologia: 1997; 29 3 125 131
80. Comhaire F. H., Christophe A. B., Zalata A. A., Dhooge W. S., Mahmoud A. M., Depuydt C. E. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fatty Acids: 2000; 63 3 159 165
81. Safarinejad M. R., Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol: 2009; 181 2 741 751
82. Gavella M., Lipovac V. Pentoxifylline-mediated reduction of superoxide anion production by human spermatozoa. Andrologia: 1992; 24 1 37 39
83. Gavella M., Lipovac V., Marotti T. Effect of pentoxifylline on superoxide anion production by human sperm. Int J Androl: 1991; 14 5 320 327
84. Pang S. C., Chan P. J., Lu A. Effects of pentoxifylline on sperm motility and hyperactivation in normozoospermic and normokinetic semen. Fertil Steril: 1993; 60 2 336 343
85. Marrama P., Baraghini G. F., Carani C., et al. Further studies on the effects of pentoxifylline on sperm count and sperm motility in patients with idiopathic oligo-asthenozoospermia. Andrologia: 1985; 17 6 612 616
86. Yovich J. M., Edirisinghe W. R., Cummins J. M., Yovich J. L. Influence of pentoxifylline in severe male factor infertility. Fertil Steril: 1990; 53 4 715 722
87. Tesarik J., Thébault A., Testart J. Effect of pentoxifylline on sperm movement characteristics in normozoospermic and asthenozoospermic specimens. Hum Reprod: 1992; 7 9 1257 1263
88. Okada H., Tatsumi N., Kanzaki M., Fujisawa M., Arakawa S., Kamidono S. Formation of reactive oxygen species by spermatozoa from asthenospermic patients: response to treatment with pentoxifylline. J Urol: 1997; 157 6 2140 2146
89. Chia S. E., Ong C. N., Chua L. H., Ho L. M., Tay S. K. Comparison of zinc concentrations in blood and seminal plasma and the various sperm parameters between fertile and infertile men. J Androl: 2000; 21 1 53 57
90. Omu A. E., Al-Azemi M. K., Kehinde E. O., Anim J. T., Oriowo M. A., Mathew T. C. Indications of the mechanisms involved in improved sperm parameters by zinc therapy. Med Princ Pract: 2008; 17 2 108 116
91. Omu A. E., Al-Qattan F., Al-Abdul-Hadi F. M., Fatinikun M. T., Fernandes S. Seminal immune response in infertile men with leukocytospermia: effect on antioxidant activity. Eur J Obstet Gynecol Reprod Biol: 1999; 86 2 195 202
92. Hartoma T. R., Nahoul K., Netter A. Zinc, plasma androgens and male sterility. [letter]. Lancet: 1977; 2 8048 1125 1126
93. Tikkiwal M., Ajmera R. L., Mathur N. K. Effect of zinc administration on seminal zinc and fertility of oligospermic males. Indian J Physiol Pharmacol: 1987; 31 1 30 34
94. Atig F., Raffa M., Ali H. B., Abdelhamid K., Saad A., Ajina M. Altered antioxidant status and increased lipid per-oxidation in seminal plasma of tunisian infertile men. Int J Biol Sci: 2012; 8 1 139 149
95. Wong W. Y., Thomas C. MG, Merkus J. MWM, Zielhuis G. A., Steegers-Theunissen R. PM. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril: 2000; 73 3 435 442
96. Ebisch I. M., Pierik F. H., DE Jong F. H., Thomas C. M., Steegers-Theunissen R. P. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl: 2006; 29 2 339 345
97. Gregory J., Foster K., Tyler H., Wiseman M. The dietary and nutritional survey of British adults. In: Office of Population Censuses and Surveys. London HMSO: 1990
98. de Bree A., van Dusseldorp M., Brouwer I. A., van het Hof K. H., Steegers-Theunissen R. P. Folate intake in Europe: recommended, actual and desired intake. Eur J Clin Nutr: 1997; 51 10 643 660
99. Landau B., Singer R., Klein T., Segenreich E. Folic acid levels in blood and seminal plasma of normo- and oligospermic patients prior and following folic acid treatment. Experientia: 1978; 34 10 1301 1302
100. Ghishan F. K., Said H. M., Wilson P. C., Murrell J. E., Greene H. L. Intestinal transport of zinc and folic acid: a mutual inhibitory effect. Am J Clin Nutr: 1986; 43 2 258 262
101. Quinn P. B., Cremin F. M., O'Sullivan V. R., Hewedi F. M., Bond R. J. The influence of dietary folate supplementation on the incidence of teratogenesis in zinc-deficient rats. Br J Nutr: 1990; 64 1 233 243
102. Favier M., Faure P., Roussel A. M., Coudray C., Blache D., Favier A. Zinc deficiency and dietary folate metabolism in pregnant rats. J Trace Elem Electrolytes Health Dis: 1993; 7 1 19 24
103. Wong W. Y., Merkus H. M., Thomas C. M., Menkveld R., Zielhuis G. A., Steegers-Theunissen R. P. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril: 2002; 77 3 491 498
104. Tremellen K., Miari G., Froiland D., Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gynaecol: 2007; 47 3 216 221
105. Lewin A., Lavon H. The effect of coenzyme Q10 on sperm motility and function. Mol Aspects Med: 1997; 18 (Suppl): S213 S219
106. Thomas S. R., Neuzil J., Stocker R. Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in atherogenesis? Mol Aspects Med: 1997; 18 (Suppl): S85 S103
107. Baker H. W., Brindle J., Irvine D. S., Aitken R. J. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril: 1996; 65 2 411 419
108. Biewenga G. P., Haenen G. R., Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol: 1997; 29 3 315 331
109. Gyllenborg J., Skakkebaek N. E., Nielsen N. C., Keiding N., Giwercman A. Secular and seasonal changes in semen quality among young Danish men: a statistical analysis of semen samples from 1927 donor candidates during 1977-1995. Int J Androl: 1999; 22 1 28 36
110. Jorgensen N., Andersen A. G., Eustache F., et al. Regional differences in semen quality in Europe. Hum Reprod: 2001; 16 5 1012 1019
111. von Eckardstein S., Syska A., Gromoll J., Kamischke A., Simoni M., Nieschlag E. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab: 2001; 86 6 2585 2590
112. Aitken R. J., De Iuliis G. N. Origins and consequences of DNA damage in male germ cells. Reprod Biomed Online: 2007; 14 6 727 733
113. Alvarez J. G. Nurture vs nature: how can we optimize sperm quality? J Androl: 2003; 24 5 640 648
114. Ko E. Y., Sabanegh E. S. Jr. The role of over-the-counter supplements for the treatment of male infertility-fact or fiction? J Androl: 2012; 33 3 292 308